High dose OIT for peanut hypersensitivity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 20 Dec 2021: Trial registered, NCT05163574

The trials

NCT05163574: Induction of Sustained Unresponsiveness to Peanuts Using High- and Low-dose Peanut Oral Immunotherapy

State
State not given
Phase
No phase
People
40 planned
Started
5 Feb 2022
Primary completion
31 Dec 2023
Arms
High dose
Results
None posted
  1. 20 Dec 2021: Trial registered
  2. 5 Feb 2022: Trial started

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Diet or lifestyle.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.